Michael A. Fischbach

Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential

M. Fischbach, S. Hazen, A. Lusis, 2018, Circulation research.

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

Oliver Fiehn, Michael A. Fischbach, Joseph A. DiDonato, 2020, Cell.

Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure

I. Demuth, Yuping Wu, A. Haghikia, 2023, European journal of heart failure.

Microbe-derived uremic solutes enhance thrombosis potential in the host

S. Mazmanian, Kymberleigh A. Romano, Sarah M. Skye, 2023, mBio.

Gut microbiota gate host exposure to metabolites from dietary Solanums

S. Higginbottom, P. Murugkar, Jakub Rajniak, 2024, bioRxiv.

Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors

S. N. Naga Prasad, M. Mohan, J. DiDonato, 2024, Nature communications.

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

M. Fischbach, S. Almo, M. Medema, 2019, bioRxiv.